These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9535392)

  • 1. Antimicrobial susceptibility testing of a clinical isolate of vancomycin-dependent enterococcus using D-alanine-D-alanine as a growth supplement.
    Sng LH; Cornish N; Knapp CC; Ludwig MD; Hall GS; Washington JA
    Am J Clin Pathol; 1998 Apr; 109(4):399-403. PubMed ID: 9535392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Microbiological and epidemiological characteristics of vancomycin-dependent enterococci].
    Hwang K; Sung H; Namgoong S; Yoon NS; Kim MN
    Korean J Lab Med; 2009 Aug; 29(4):299-306. PubMed ID: 19726891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility and species identification for clinical isolates of enterococci.
    Hsieh SR
    J Microbiol Immunol Infect; 2000 Dec; 33(4):253-7. PubMed ID: 11269371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp.
    Williams JD; Maskell JP; Whiley AC; Sefton AM
    J Antimicrob Chemother; 1997 May; 39 Suppl A():41-6. PubMed ID: 9511061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Epidemiology of Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium Isolated from Clinical Specimens in the Northwest of Iran.
    Jahansepas A; Ahangarzadeh Rezaee M; Hasani A; Sharifi Y; Rahnamaye Farzami M; Dolatyar A; Aghazadeh M
    Microb Drug Resist; 2018 Oct; 24(8):1165-1173. PubMed ID: 29708837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.
    Louie A; Baltch AL; Ritz WJ; Smith RP; Asperilla M
    Chemotherapy; 1993; 39(5):302-9. PubMed ID: 8396526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypes and genotypes of vancomycin-resistant enterococci isolated during long-term follow-up in a patient with recurrent bacteremia and colonization.
    Yeh KM; Lu JJ; Siu LK; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2002 Dec; 35(4):243-8. PubMed ID: 12542250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing therapy for vancomycin-resistant enterococci (VRE).
    Linden PK
    Semin Respir Crit Care Med; 2007 Dec; 28(6):632-45. PubMed ID: 18095227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance of enterococci in Turkey.
    Kaçmaz B; Aksoy A
    Int J Antimicrob Agents; 2005 Jun; 25(6):535-8. PubMed ID: 15908184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibilities of clinical isolates of vancomycin-resistant enterococci in Taiwan.
    Hsueh PR; Wu JJ; Lu JJ; Teng LJ; Luh KT
    J Formos Med Assoc; 1999 Jan; 98(1):45-8. PubMed ID: 10063273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vancomycin-resistant enterococci: in vitro activity of quinupristin / dalfoprostin (RP 59500)].
    Betriu C; Valverde JF; Culebras E; Gómez M; Sánchez A; Palau ML; Picazo JJ
    Enferm Infecc Microbiol Clin; 1999; 17(7):335-9. PubMed ID: 10535185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE.
    Olivier CN; Blake RK; Steed LL; Salgado CD
    Infect Control Hosp Epidemiol; 2008 May; 29(5):404-9. PubMed ID: 18419361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility of enterococci recovered from healthy cattle, pigs and chickens in nine EU countries (EASSA Study) to critically important antibiotics.
    de Jong A; Simjee S; Garch FE; Moyaert H; Rose M; Youala M; Dry M;
    Vet Microbiol; 2018 Mar; 216():168-175. PubMed ID: 29519512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic and disinfectant susceptibility profiles of vancomycin-resistant Enterococcus faecium (VRE) isolated from community wastewater in Texas.
    Beier RC; Duke SE; Ziprin RL; Harvey RB; Hume ME; Poole TL; Scott HM; Highfield LD; Alali WQ; Andrews K; Anderson RC; Nisbet DJ
    Bull Environ Contam Toxicol; 2008 Mar; 80(3):188-94. PubMed ID: 18193143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of vancomycin-resistant Enterococcus faecium: potential utility of fosfomycin.
    Shrestha NK; Chua JD; Tuohy MJ; Wilson DA; Procop GW; Longworth DL; Isada CM; Hall GS
    Scand J Infect Dis; 2003; 35(1):12-4. PubMed ID: 12685877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic susceptibility testing (agar disk diffusion and agar dilution) of clinical isolates of Enterococcus faecalis and E. faecium: comparison of Mueller-Hinton, Iso-Sensitest, and Wilkins-Chalgren agar media.
    Traub WH; Geipel U; Leonhard B
    Chemotherapy; 1998; 44(4):217-29. PubMed ID: 9681198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypic characterization of a nosocomial outbreak of VanA Enterococcus faecalis.
    Biavasco F; Miele A; Vignaroli C; Manso E; Lupidi R; Varaldo PE
    Microb Drug Resist; 1996; 2(2):231-7. PubMed ID: 9158765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: comparison with a control cohort.
    Linden PK; Pasculle AW; McDevitt D; Kramer DJ
    J Antimicrob Chemother; 1997 May; 39 Suppl A():145-51. PubMed ID: 9511079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.